News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
TraceLink and PharmaLink Partner to Simplify DSCSA Compliance for Pharmacies, Hospitals, and Healthcare Providers
Tuesday, May 23, 2023TraceLink Inc the leading digital network platform company enabling endtoend product orchestration by connecting more than healthcare and life sciences entities through its BN IntegrateOnce network announced a partnership with PharmaLink the nations...
Vesselon Discovery Protects and Expands Drug Franchises
Tuesday, May 23, 2023In a major development Vesselon has discovered how to protect a superior method of delivering drugs shown to be effective in more than independent preclinical and cliniciansponsored human trials Despite compelling evidence that the method improves t...
Haisate Pharmaceuticals announced that the US FDA approved its Phase III clinical trial of TC Ointment, the world's first new plant small molecule drug for the treatment of psoriasis vulgaris
Tuesday, May 23, 2023Hessate Pharmaceuticals announced today through its whollyowned research institution Guangzhou Psoriasis Research Institute PRIG that based on the completed Phase IIb of the new drug in the United States Clinical trial NCT the US Food and Drug Admini...
Lifecore Biomedical Enters into $150.0 Million in New Financing
Tuesday, May 23, 2023Lifecore Biomedical Inc Lifecore or the Company Nasdaq LFCR a fully integrated contract development and manufacturing organization CDMO today announced that it has entered into a broad set of agreements with its longterm customer Alcon SIXNYSE ALC wh...
HiST Pharma Announces U.S. FDA Approval to Start a Phase III Clinical Trial of TC Cream - the World's First Plant-Based "Small Molecule" Drug to Treat Psoriasis Vulgaris
Monday, May 22, 2023HiST Pharma through its wholly owned Psoriasis Research Institute of Guangzhou PRIG announces today that it has received approval from the US Food and Drug Administration FDA to develop its new investigational drug IND Include TC Cream for the treatm...
AlzeCure's Alzheimer project NeuroRestore ACD856 is also granted a European patent
Monday, May 22, 2023AlzeCure Pharma AB publ FN STO ALZCUR developing small molecule drug candidates for CNS diseases focusing on Alzheimers disease and pain announced today that the European Patent Office EPO has granted a patent covering the companys drug candidate ACD...
FDA Approves First Topical Gene Therapy for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
Saturday, May 20, 2023Today the US Food and Drug Administration approved Vyjuvek a herpessimplex virus type HSV vectorbased gene therapy for the treatment of wounds in patients months of age and older with dystrophic epidermolysis bullosa DEB with mutations in the colla...
RZNOMICS Inc. received FDA approval to initiate clinical development of trans-splicing ribozyme-based RNA editing technology in Glioblastoma Multiforme Patients
Saturday, May 20, 2023Rznomics Inc a South Korea based biopharmaceutical company specialized in the development of RNAbased gene therapeutics recently received Phase a IND approval from the US FDA on May th for its Glioblastoma Multiforme GBM treatment called RZ and thus...
The world's first such vaccine: The multivalent recombinant protein vaccine against XBB variant of COVID-19 from WestVac Biopharma
Saturday, May 20, 2023Bivalent Recombinant COVID Protein Vaccine Sf Cells and Trivalent Recombinant COVID Trimeric Protein Vaccine Sf Cells developed by WestVac BiopharmaWest China Medical Center Sichuan University against the most recent circulating XBB variants have rec...
Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) for the Treatment of the Signs and Symptoms of Dry Eye Disease
Friday, May 19, 2023Bausch Lomb Corporation NYSETSX BLCO Bausch Lomb a leading global eye health company dedicated to helping people see better to live better and Novaliq GmbH a biopharmaceutical company focusing on first and bestin class ocular therapeutics today ann...
